(Q83801541)

English

Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management

scientific article published on 08 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Laurence Champion

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Veronique Edeline

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Etienne Brain

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Anne-Laure Giraudet

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Elise Le Stanc

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Myriam Wartski

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Dominique Bellet

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Alain Pecking

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Jean-Louis Alberini

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

8 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1621-1629

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

The Place of Whole-Body PET FDG for the Diagnosis of Distant Recurrence of Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

18F-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of FDG-PET/CT in suspected recurrence of breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation among [18F]fluorodeoxyglucose positron emission tomography/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrence.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-D-glucose in murine models of breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Triple-negative breast cancer--current status and future directions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum CA15-3 levels correlate with positive estrogen receptor and initial favorable outcome in patients who died from recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25727

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25727

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21472709%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83801541&oldid=1424905659"